期刊文献+

脂肪肝患者血清载脂蛋白CⅢ检测的临床意义 被引量:2

Clinical Significance of Measuring Serum Apoprotein C Ⅲ in Patients with Fatty Liver
下载PDF
导出
摘要 用免疫扩散法检测63例脂肪肝患者血清载脂蛋白CⅢ的含量并与正常人及慢性肝病者进行对照,结果表明脂肪肝患者载脂蛋白CⅢ(apoCⅢ)水平明显高于其它两组(P<0.01),认为apoCⅢ升高与脂肪肝形成有关,可作为脂肪肝诊断及疗效监测指标。 We measured the levels of serum Apoprotein C Ⅲ with immunodiffusion test in 63 cases of patient with fatty liver,20 cases of patients with chronic liver disease and normal control respectively. The results showed that the levels of apo C Ⅲ in the patients with fatty lever were higher than those in the others significantly(p<0.01). We concluded that the elevated level of apo C Ⅲ might be related to the fatty liver, and apo C Ⅲ could served as an index of diagnosing or assessing curative effect of fatty liver.
作者 白先慧
机构地区 广西区人民医院
出处 《广西医学》 CAS 1997年第3期337-338,共2页 Guangxi Medical Journal
关键词 脂肪肝 载脂蛋白 血清 诊断 疗效 fatty liver apoprotein C Ⅲ
  • 相关文献

参考文献1

二级参考文献1

  • 1徐广逵,冯根宝,武建国.火箭免疫电泳法检测人血清载脂蛋白B与临床应用[J]解放军医学杂志,1986(05).

共引文献4

同被引文献14

  • 1陈世清,刘杞,孙航,张桂灵,石小枫.脂肪肝胰岛素抵抗大鼠模型的建立[J].中华肝脏病杂志,2005,13(2):105-108. 被引量:46
  • 2Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome[J]. Diabetes, 2003, 50(8): 1844.
  • 3Samuel V T, Liu Z X, Qu X, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease [ J ]. Biol Chem, 2004, 279: 32345.
  • 4Neuschwander-Teri B A, Caldwell S H. Nonalcoholic steatohepatitits: summary of an AASLD Single Topic Conference [J]. Hepatology, 2003, 37: 1202.
  • 5Askinen M R. Insulin resistance and lipoprotein metabolism [J]. Curr Opin Lipidology, 1992, 6: 15.
  • 6Choudhttry J, Sanyal A J. Insulin resistance and pathogenesis of nonalcoholic fatty liver disease[J]. Clin liver Dis, 2004, 8: 575.
  • 7Bradbury M W, Berk P D. Lipid metabolism in hepatic steatosis[J]. Clin liver Dis, 2004, 8: 639.
  • 8Robert H. Eckel. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD[J]. Proceeding of the nutrition Society, 2007, 66: 82.
  • 9Grutzmacher P, Berglund L, Heimburgero O, et al. Lipoproteins and apolipoprotein during the progression of chronic renal discase [ J ]. Nephron, 1998,50(4) : 103 - 104.
  • 10Selimogu MA,Aydogdu S, Yagei RV. Lipid prameters parameters in childhood cirrhosis andchronic liver disease[ J ]. Pedialr Int ,2004,44 (4) :400 -403.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部